Amitriptyline: A Tricyclic Antidepressant Developed For the Treatment of Anxiety and Depression
Amitriptyline Market Amitriptyline belongs to the tricyclic antidepressant family. The drug was developed for the treatment of anxiety and depression. It works on the central nervous system (CNS) to increase levels of certain chemicals in the brain. It is also effective in pain management when used in low dosage. Other uses of the drug include, anxiety, chronic pain (diabetic neuropathy, fibromyalgia), insomnia, irritable bowel syndrome, interstitial cystitis (bladder pain syndrome), migraine prophylaxis, post-traumatic stress disorder, postherpetic neuralgia, and sialorrhea. However, there is a lack of evidence that amitriptyline has any beneficial effect on sleep in insomnia. The global amitriptyline market is estimated to be valued at US$ 527.4 million in 2020 and is expected to exhibit a CAGR of 5.3% during the forecast period (2020-2027). Amitriptyline is commonly prescribed for the treatment of depression and nerve pain. It is also used to treat bedwetting and nocturnal